361
|
|
|
Solute carrier organic anion transporter family member 1B3 |
HBLRR, LST-2, LST-3TM13, LST3, OATP-8, OATP1B3, OATP8, SLC21A8 |
|
362
|
|
|
Serine/threonine kinase 32C |
PKE, YANK3 |
|
363
|
|
|
SBF2 antisense RNA 1 |
- |
|
364
|
|
|
Solute carrier family 25 member 45 |
- |
|
365
|
|
|
Solute carrier family 22 member 24 |
NET46 |
|
366
|
|
|
Solute carrier family 39 member 5 |
LZT-Hs7, MYP24, ZIP5 |
|
367
|
|
|
SUCLG2 pseudogene 2 |
- |
|
368
|
|
|
Solute carrier family 25 member 47 |
C14orf68, HDCMP, HDMCP, HMFN1655 |
|
369
|
|
|
Solute carrier family 24 member 5 |
JSX, NCKX5, OCA6, SHEP4 |
|
370
|
|
|
Solute carrier family 13 member 5 |
DEE25, EIEE25, INDY, NACT, mIndy |
Amelocerebrohypohidrotic syndrome, Amelogenesis imperfecta, Attention deficit hyperactivity disorder, Autism, Cerebral atrophy, Cerebral cortical atrophy, Deficiency of glutamate decarboxylase, Dementia, Developmental delay, Developmental regression, Dwarfism, Dyskinetic syndrome, Epilepsy, Epileptic encephalopathy, Fatty liver, Gastroesophageal reflux disease, Hydrocephalus, Hypodontia, Hypohidrosis, Mental retardation, Kidney disease, Kohlschutter syndrome, Microcephaly, Movement disorders, Non-specifi epileptic encephalopathy, Nystagmus, Optic atrophy, Ptosis, Pyridoxine-dependent epilepsy, Speech disorders, Status epilepticus, StrabismusView all (17 more) |